Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening
Melissa Barker‐Haliski, H. Steve White
Neuropharmacology (2019) Vol. 167, pp. 107750-107750
Open Access | Times Cited: 64

Showing 26-50 of 64 citing articles:

Reductions in Hydrogen Sulfide and Changes in Mitochondrial Quality Control Proteins Are Evident in the Early Phases of the Corneally Kindled Mouse Model of Epilepsy
Christi Cho, Maxwell Zeigler, Stephanie Mizuno, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1434-1434
Open Access | Times Cited: 11
Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital
Melissa Barker‐Haliski, Kevin M. Knox, Dannielle Zierath, et al.
Epilepsia (2021) Vol. 62, Iss. 7, pp. 1677-1688
Open Access | Times Cited: 14
SV2B defines a subpopulation of synaptic vesicles
Isabelle Paulußen, Hannes Beckert, Timothy F. Musial, et al.
Journal of Molecular Cell Biology (2023) Vol. 15, Iss. 9
Open Access | Times Cited: 5
Anti‐PD‐1 treatment protects against seizure by suppressing sodium channel function
Yuling Yang, Zhiyun Chen, Jing Zhou, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 5
Drug-Inducible Gene Therapy Effectively Reduces Spontaneous Seizures in Kindled Rats but Creates Off-Target Side Effects in Inhibitory Neurons
Kyle A. Sullivan, Iuliia Vitko, K. L. Blair, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11347-11347
Open Access | Times Cited: 5
Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy
Aarón del Pozo, Leanne M Lehmann, Kevin M. Knox, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 8
A multiorganism pipeline for antiseizure drug discovery: Identification of chlorothymol as a novel γ‐aminobutyric acidergic anticonvulsant
Alistair Jones, Melissa Barker‐Haliski, Andrei Ilie, et al.
Epilepsia (2020) Vol. 61, Iss. 10, pp. 2106-2118
Open Access | Times Cited: 11
Transient anticonvulsant effects of time-restricted feeding in the 6-Hz mouse model
Oliver J. Armstrong, Elliott S. Neal, Diana Vidovic, et al.
Epilepsy & Behavior (2024) Vol. 151, pp. 109618-109618
Open Access | Times Cited: 1
Caspase-1 inhibitor CZL80 protects against acute seizures via amplifying the inhibitory neural transmission
Yingying Tang, Yao Liu, Yiwei Gong, et al.
Neurochemistry International (2024) Vol. 179, pp. 105809-105809
Closed Access | Times Cited: 1
A relationship between intestinal microbiome and epilepsy: potential treatment options for drug-resistant epilepsy
A. S. Cherednichenko, P. V. Mozdor, T. K. Oleynikova, et al.
Epilepsy and Paroxysmal Conditions (2024) Vol. 16, Iss. 3, pp. 250-265
Open Access | Times Cited: 1
Discovery and Profiling of New Multimodal Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates
Marcin Jakubiec, Michał Abram, Mirosław Zagaja, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 17, pp. 3228-3256
Open Access | Times Cited: 1
Nanocarriers-based therapeutic strategy for drug-resistant epilepsy: A systematic review
Roberto Díaz-Peregrino, Daniel San‐Juan, Carlos Patiño-Ramirez, et al.
International Journal of Pharmaceutics (2024) Vol. 668, pp. 124986-124986
Open Access | Times Cited: 1
A companion to the preclinical common data elements for rodent genetic epilepsy models. A report of the TASK3‐WG1B: Paediatric and genetic models working group of the ILAE/AES joint translational TASK force
Massimo Mantegazza, Stéphane Auvin, Melissa Barker‐Haliski, et al.
Epilepsia Open (2022)
Open Access | Times Cited: 6
Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model
Leanne M Lehmann, Melissa Barker‐Haliski
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy
Antonio Leo, Francesca Bosco, Lorenza Guarnieri, et al.
European Journal of Pharmacology (2023) Vol. 962, pp. 176222-176222
Closed Access | Times Cited: 3
Non-synaptic Cell-Autonomous Mechanisms Underlie Neuronal Hyperactivity in a Genetic Model of PIK3CA-Driven Intractable Epilepsy
Achira Roy, Victor Z. Han, Angela M. Bard, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 6
Effect of caffeine on the anticonvulsant action of pregabalin against electroconvulsions in mice
Roman Chwedorowicz, Krzysztof Łukawski, Grzegorz Raszewski, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 2, pp. 431-437
Closed Access | Times Cited: 4
Ceftriaxone and selenium mitigate seizures and neuronal injury in pentylenetetrazole-kindled rats: Oxidative stress and inflammatory pathway
Asmaa M. Mohamed, Dina A. Ali, Eman Kolieb, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110304-110304
Closed Access | Times Cited: 2
Developing precision treatments for epilepsy using patient and animal models
Krzysztof Łukawski, Stanisław J. Czuczwar
Expert Review of Neurotherapeutics (2020) Vol. 21, Iss. 11, pp. 1241-1250
Closed Access | Times Cited: 4
Suppression of PIK3CA-driven epileptiform activity by acute pathway control
Achira Roy, Victor Z. Han, Angela M. Bard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
HPLC and GC–MS–based metabolic profiles and in vivo anticonvulsant, sedative, and antinociceptive potentials of truffles Tirmania nivea and Tirmania pinoyi hydromethanolic extracts in mice
Mona E. Aboutabl, Waill A. Elkhateeb, Marwa A. Masoud, et al.
Biomedical Chromatography (2022) Vol. 36, Iss. 12
Closed Access | Times Cited: 3
Attenuation of Epileptogenesis and Cognitive Deficits by a Selective and Potent Kv7 Channel Opener in Rodent Models of Seizures
Xiao-fei Zhuang, Yuxue Liu, Zhihong Yang, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 2, pp. 315-325
Closed Access | Times Cited: 3
Subcutaneous infection mouse model could be applied into real time monitoring the efficacy of anti-cystic echinococcosis drug in vivo
Jintian Li, Guizhi Ma, Mingzhi Yan, et al.
Acta Tropica (2022) Vol. 238, pp. 106802-106802
Closed Access | Times Cited: 3
Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies
Chih‐Sheng Yang, Man-Chun Wu, Ming‐Chi Lai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13143-13143
Open Access | Times Cited: 1
What we have learned from non-human primates as animal models of epilepsy
Viviam Sanabria, Simone Romariz, Matheus Braga, et al.
Epilepsy & Behavior (2024) Vol. 154, pp. 109706-109706
Closed Access

Scroll to top